This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Tincture contains 15 mg dose of CBN and THC per milliliter.
Parallel’s retail brand goodblend has introduced a new product featuring cannabinol (CBN) for patients registered in the Texas Compassionate Use Program.
The Surterra Wellness Dream +CBN tincture marks the fifth first-to-market product innovation the company has launched in the Lone Star State in the last nine months, following the launch of Texas' first medical cannabis capsule format for qualifying patients. Earlier this week, Parallel's Massachusetts retail brand, New England Treatment Access (NETA), launched a Surterra Wellness Dream +CBN product, making it the first CBN product offered to its customers.